Intellia Therapeutics, Inc. (NTLA)
14.95
+0.79
(+5.58%)
USD |
NASDAQ |
Apr 17, 16:00
14.90
-0.05
(-0.33%)
After-Hours: 16:29
Intellia Therapeutics EPS Diluted (Quarterly) : -0.8263 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Recursion Pharmaceuticals, Inc. | -0.2053 |
| Personalis, Inc. | -0.258 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| Novavax, Inc. | 0.1061 |
| KalVista Pharmaceuticals, Inc. | -0.1055 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -95.79M |
| Revenue (Quarterly) | 23.02M |
| Total Expenses (Quarterly) | 118.80M |
| Enterprise Value | 1.316B |
| Gross Profit Margin (Quarterly) | 73.87% |
| Profit Margin (Quarterly) | -416.2% |
| Earnings Yield | -25.60% |
| Normalized Earnings Yield | -25.27 |